Site icon OncologyTube

Future role of immunotherapy and checkpoint inhibitors in urothelial cancer #GU16

Robert Dreicer, MD of the University of Virginia Health System discusses the future role of immunotherapy and checkpoint inhibitors in urothelial cancer at ASCO GU 2016.

Exit mobile version